The Role of Partial Enteral Nutrition for Induction of Remission in Crohn's Disease: A Systematic Review of Controlled Trials

Nutrients. 2022 Dec 9;14(24):5263. doi: 10.3390/nu14245263.

Abstract

Exclusive enteral nutrition (EEN) is recommended as a first-line therapy to induce remission of Crohn's disease (CD) and is considered as effective as corticosteroid treatment. However, the dietary restriction causes lack of adherence and poor tolerance to the therapy. Partial enteral nutrition (PEN), which allows for the ingestion of some food, could be a better tolerated alternative, but it is unknown whether it is as effective at inducing CD remission as EEN. The aim of this systematic review is to analyze the available evidence on PEN as a remission induction therapy in CD. A literature search was conducted using the MEDLINE (via PUBMED) and Cochrane Library databases following the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. Clinical trials in pediatric and adult patients were included. The risk of bias was assessed following the Cochrane Collaboration methodology. The selected studies showed variable but high response rates to PEN and EEN. Limitations regarding the wide heterogeneity between the studies included in this review should be considered. Although more studies are needed, according to our results, PEN combined with a highly restrictive diet seems to be as effective as EEN in inducing remission of CD.

Keywords: Crohn’s disease; diet; enteral nutrition; inflammatory bowel disease; nutritional therapy.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Child
  • Crohn Disease*
  • Enteral Nutrition* / methods
  • Food, Formulated
  • Humans
  • Randomized Controlled Trials as Topic
  • Remission Induction

Substances

  • Adrenal Cortex Hormones

Grants and funding

This research received no external funding. Professor Novoa Santos Foundation financially supported the publication of the article.